Several studies have previously been conducted studying the effects of ITPA polymorphisms on treatment outcome in ALL patients [7], [21], [22], [24], [25]; however, most of them focused on evaluating the effect of ITPA genotype on treatment-related toxicities and only a few on long-term survival. Here, ITPA is linked to acute lymphoblastic leukemia.